25
TAFENOQUINE: A NOVEL PREVENTATIVE TREATMENT FOR MALARIA IN G-6-P-D DEFICIENT PATIENTS Prepared for LEO Pharma January 14, 2011 By M. Christian Armstrong, M.D. M.H.S.A.

G6 Pd Presentation

Embed Size (px)

DESCRIPTION

Presentation for MSL interview for Leo Pharma.

Citation preview

Page 1: G6 Pd Presentation

TAFENOQUINE: A NOVEL PREVENTATIVE TREATMENT FOR MALARIA IN G-6-P-D DEFICIENT PATIENTS

Prepared for LEO Pharma

January 14, 2011

By M. Christian Armstrong, M.D. M.H.S.A.

Page 2: G6 Pd Presentation

Malaria G6PD Def.

Tafenoquine

Page 3: G6 Pd Presentation

Malaria

MalariaHalf of the global population at risk*

* http://www.cdc.gov/malaria/about/facts.html

Page 4: G6 Pd Presentation

Malaria

* http://www.cdc.gov/malaria/about/facts.html

Page 5: G6 Pd Presentation

Malaria

* http://www.cdc.gov/malaria/about/facts.html

Page 6: G6 Pd Presentation

Malaria

MalariaHalf of the global population at risk*

2008○ Up to 311 million cases*

○ Up to 1,003,000 deaths*

* http://www.cdc.gov/malaria/about/facts.html

Page 7: G6 Pd Presentation

Malaria

What is Malaria?A parasite infection*

○ Infects the blood stream

Flu-like symptoms*

○ High fever○ Chills/Shaking

Death*

○ 1 child <5 years old every 30 seconds**

* http://www.cdc.gov/malaria/about/facts.html** Butcher, G. A.; Sinden, R. E.; Curtis, C. Malaria: New ideas, old problems, new technologies. Parasitol. Today 2000, 16, 43–44.

Page 8: G6 Pd Presentation

Malaria Malaria Treatment

chloroquine atovaquone-proguanil (Malarone®)artemether-lumefantrine

(Coartem®)mefloquine (Lariam®) quininequinidinedoxycycline (used in combination

with quinine)clindamycin (used in combination

with quinine)primaquine

* http://www.cdc.gov/malaria/about/facts.html

Page 9: G6 Pd Presentation

Malaria G6PD Def.

Page 10: G6 Pd Presentation

G6PD Deficiency

Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency

MC enzyme deficiency worldwide Approximately 400 million people affected*

MC populations: African, Asian, Mediterranean, or Middle-

Eastern descent*

In the USA up to 10% black males are affected*

* Frank, J.E. (2005). Diagnosis and management of g6pd deficiency. American Family Physician, 72(7), 1277-1282.

Page 11: G6 Pd Presentation

G6PD Deficiency

What is G6PD?It is a disease state that causes acute

hemolysis (RBC’s break apart) when the patient has an infection, ingestion of fava beans, or exposure to an oxidative drug.*

* Frank, J.E. (2005). Diagnosis and management of g6pd deficiency. American Family Physician, 72(7), 1277-1282.

Page 12: G6 Pd Presentation

G6PD Deficiency

Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency TreatmentAvoidance

○ Fava beans – Mediterranean Diet○ Infection – causes oxidative stress○ Oxidant Drugs – “AAA”

Antibiotics (sulfa drugs)AntipyreticsAntimalarials??? “AAA”

Page 13: G6 Pd Presentation

G6PD Deficiency

Inherited – X-linked, Recessive

Page 14: G6 Pd Presentation

G6PD Deficiency

Page 15: G6 Pd Presentation

G6PD Deficiency

Oxidative stress causes the RBC’s to break apart

Inherited – X-linked, Recessive Biochemistry

Page 16: G6 Pd Presentation

G6PD Deficiency

Biochemistry – summary

• G6PD

Reduces

• NADP+

• to• NADPH

Which is responsible for • Glutathione

Which fights

• Free radicals

Which damage blood cells

Page 17: G6 Pd Presentation

G6PD Deficiency

Why is the biochemistry important?Understand how the drugs cause the

oxidative stress. Remember “AAA”?

Antibiotics (sulfa drugs)AntipyreticsAntimalarials???

Antimalarials

Page 18: G6 Pd Presentation

G6PD Deficiency

Malaria Treatmentchloroquineatovaquone-proguanil (Malarone®)artemether-lumefantrine (Coartem®)mefloquine (Lariam®) quininequinidinedoxycycline (used in combination with quinine)clindamycin (used in combination with quinine)primaquine

“quin” Drugs

Page 19: G6 Pd Presentation

Malaria G6PD Def.

Tafenoquine

Page 20: G6 Pd Presentation

Tafenoquine

What is tafenoquine?An 8-aminoquinoline (8-AQ) antimalairal* Same family as pamaquine and primaquine*

Derivative of primaquine*

*Shiraki, H. (2011). Antimalarial activity of novel 5-aryl-8-aminoquinoline derivatives. Journal of Medicinal Chemistry, 54, 131-142.

Page 21: G6 Pd Presentation

Tafenoquine Problem with

Primaquine5-hydroxy-8-

aminoquinolines○ Semiquinoneimine

radical formation*

○ Iminoquinolione formation*

Derivatives formed○ Lost anitmalarial

activity*

○ Retained hemolytic toxicity*

*Shiraki, H. (2011). Antimalarial activity of novel 5-aryl-8-aminoquinoline derivatives. Journal of Medicinal Chemistry, 54, 131-142.

Page 22: G6 Pd Presentation

Tafenoquine vs. Primaquine Tafenoquine

Less toxicLonger Acting

○ Weekly dosingMore Potent

○ At least 10 times more potent than primaquine

PrimaquineMore toxicSorter Acting

○ Daily dosingLess potent

Page 23: G6 Pd Presentation

5-(m-trifluoromethylphenyl)

Tafenoquine vs. Primaquine

Page 24: G6 Pd Presentation

Tafenoquine

*Shiraki, H. (2011). Antimalarial activity of novel 5-aryl-8-aminoquinoline derivatives. Journal of Medicinal Chemistry, 54, 131-142.

Latest Research:Parent compounds of primaquine and

tafenoquine may be the active species*Metabolites are responsible for toxicity*Next round of research will study hemolytic

side effect in G6PD deficient condition*

Page 25: G6 Pd Presentation

Malaria G6PD Def.

Tafenoquine

?